“The evidence of how additional screening with an ultrasound, MR, or 3-D mammography may or may not help women with dense breasts is unclear,” the statement noted. “Therefore, the Task Force cannot make a recommendation for or against additional screening. These are all important areas for future research.”
In preparing its final report, the Task Force reviewed every comment received and made updates based on the comments. The Task Force said it updated or clarified terminology, such as “digital breast tomosynthesis”, and clarified the difference between misdiagnosis and over-diagnosis. The report also contains more context on potential radiation exposure risks during mammography.
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Dr. Daniel Kopans, who supports annual mammography starting at 40, is among the specialists who are against the recommendations. A professor of radiology at Harvard Medical School and director of breast imaging at Massachusetts General Hospital, Kopans is known as the “father of breast tomosynthesis”. He
told HCB News in April that the Task Force did not have any breast cancer experts on it and therefore placed too much emphasis on “false positives.”
Kopans said he agreed with the American College of Radiology that had claimed adoption of the recommendations would lead to thousands of additional breast cancer deaths each year.
Back to HCB News
